Valuation: Qlife Holding AB

Market Cap 25.44M 2.49M 2.27M 2.09M 1.9M 3.57M 231M 3.75M 10.11M 126M 9.34M 9.15M 395M P/E 2024
-0.26x
P/E 2025 -1.73x
Enterprise Value 38.46M 3.77M 3.43M 3.16M 2.87M 5.39M 349M 5.67M 15.29M 190M 14.13M 13.83M 598M EV / Sales 2024
222x
EV / Sales 2025 178x
Free-Float
100%
Yield 2024 *
-
Yield 2025 -
1 day-1.34%
1 week-11.90%
Current month-18.27%
1 month-11.90%
3 months-52.28%
6 months-55.91%
Current year-68.98%
1 week 0.81
Extreme 0.807
0.96
1 month 0.65
Extreme 0.651
1.56
Current year 0.65
Extreme 0.651
3.09
1 year 0.65
Extreme 0.651
3.8
3 years 0.65
Extreme 0.651
179
5 years 0.65
Extreme 0.651
69,900
10 years 0.65
Extreme 0.651
120,000
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 01/01/2019
Chief Executive Officer 59 11/10/2019
Director of Finance/CFO 60 01/11/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2021
Director/Board Member 52 01/01/2023
Chairman 61 21/03/2025
Date Insider Type Main position Quantity % Market Cap. Importance
14/06/23 Free

Chief Executive Officer

12,697,080 2.1166%
14/06/23
Qlife ApS
OthersCompany 40,630,656 6.7731%
13/06/23 Free

Chief Financial Officer

5,078,832 0.8466%
Change 5-day change 1-year change 3-year change Capi.($)
-1.34%-11.90%-37.52%-98.51% 2.49M
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
Average -1.22%-3.55%-12.05%+7.25% 77B
Weighted average by Cap. -1.04%-2.97%-12.44%+15.68%

Financials

2024 2025
Net sales 50K 4.9K 4.46K 4.11K 3.74K 7.01K 453K 7.37K 19.87K 248K 18.37K 17.98K 777K 324K 31.72K 28.89K 26.62K 24.22K 45.43K 2.94M 47.75K 129K 1.6M 119K 117K 5.04M
Net income -55.92M -5.47M -4.99M -4.59M -4.18M -7.84M -507M -8.24M -22.23M -277M -20.54M -20.11M -869M -20.56M -2.01M -1.83M -1.69M -1.54M -2.88M -186M -3.03M -8.17M -102M -7.55M -7.39M -319M
Net Debt 5.98M 586K 534K 492K 447K 839K 54.25M 882K 2.38M 29.63M 2.2M 2.15M 92.99M 13.02M 1.27M 1.16M 1.07M 973K 1.83M 118M 1.92M 5.18M 64.49M 4.78M 4.68M 202M
Projected Income Statement - Annual - Qlife Holding AB
Logo Qlife Holding AB
Qlife Holding AB is a Sweden-based medical technology Company that manufactures the hardware and software platform Egoo.health (Egoo) with which patients can carry out various types of biomarker tests based on a small amount of blood. Egoo performs analyzes that correlate to over 99 percent with high-performance laboratory instruments. The Egoo instrument measures biomarkers for the chronic diseases Phenylketonuria (PKU), rheumatoid arthritis (RA) and cancer. Qlife Holding is the parent company of the wholly owned Danish medical technology subsidiary Qlife ApS. Qlife ApS develops a medical technology product with the long-term goal of giving people access to safe and valid biomarker data at home.
Employees
2
Date Price Change Volume
20/11/26 SEK 0.8810 -1.34% 17,621
19/11/26 SEK 0.8930 -5.00% 142,172
18/11/26 SEK 0.9400 -1.47% 12,422
17/11/26 SEK 0.9540 +8.66% 86,949
16/11/26 SEK 0.8780 -12.20% 86,902

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Qlife Holding AB
  1. Stock Market
  2. Stocks
  3. QLIFE Stock